Home › Companies › IRadimed Corporation › 2025-2026

IRadimed Corporation 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and IRadimed Corporation’s Form 8-K, filed June 24, 2026 (Item 5.07 on EDGAR). Page generated October 18, 2026.

  • 7Ballot items
  • 280Asset managers
  • 1,875Fund votes
  • June 23, 2026Meeting date

Results at a glance

Meeting of June 23, 2026: 7 items on IRadimed Corporation’s Form 8-K, filed June 24, 2026: 5 elected · 2 approved.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore IRadimed Corporation in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by IRadimed Corporation

These tallies are IRadimed Corporation’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 24, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

IRadimed Corporation — official shareholder meeting results, meeting held June 23, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Roger Susi 8,638,178---- 1,972,758759,594 81%Elected—
Elect Director: Monty Allen 9,266,549---- 1,344,387759,594 87%Elected—
Elect Director: Joe Kiani 10,492,206---- 118,730759,594 99%Elected—
Elect Director: Hilda Scharen-Guivel 10,409,481---- 201,455759,594 98%Elected—
Elect Director: James Hawkins 8,244,802---- 2,366,134759,594 78%Elected—
2. The selection of RSM US LLP as Iradimed's independent registered public accounting firm to perform independent audit services for the fiscal year ending December 31, 2026, as set forth below 11,355,8918,7165,923 ---- 99.9%Approved—
3. An advisory resolution on the compensation of Iradimed's named executive officers 10,487,387106,03017,519 --759,594 99%Approved—

This meeting is also recorded here as June 24, 2026; both records come from the same filing, so the date should be checked against it.

Source: IRadimed Corporation, Form 8-K, filed with the SEC on June 24, 2026 — read the filing on EDGAR.

How asset managers voted at the IRadimed Corporation 2025-2026 meeting

Each item below shows how the 280 asset managers that disclosed a IRadimed Corporation vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Hilda Scharen-Guivel

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 10,409,481WITHHELD: 201,455
Details: description as filed, official tally, votes by 77 asset managers

Description as filed by funds: Election of Directors: Hilda Scharen-Guivel

IRadimed Corporation’s own tally for this item (“Elect Director: Hilda Scharen-Guivel”): 10,409,481 for, 201,455 withheld, per its Form 8-K filed June 24, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Stockholders elected each of Roger Susi, Monty Allen, Joe Kiani, Hilda Scharen-Guivel and James Hawkins to Iradimed's Board of Directors, each to hold office until a succeeding annual meeting of stockholders or until such director's successor shall have been duly elected and qualified (or, if earli…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 77 asset managers below reported 2,307,786 for, 88,706 withheld.

FOR
FOR: 2,307,786WITHHOLD: 88,706
Largest asset managers voting on “Election of Directors: Hilda Scharen-Guivel” at IRadimed Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard470,3620 00For
BlackRock423,1790 00For
Fidelity336,0410 00For
T. Rowe Price167,5850 00For
Virtus149,8080 00For
Jackson National98,5510 00For
TIAA00 084,792Withhold
First Trust76,3550 00For
Charles Schwab66,7830 00For
Dimensional51,6780 00For
Goldman Sachs51,1080 00For
Russell Investments45,9050 00For
Calamos43,4310 00For
WisdomTree36,3360 00For
Victory Capital26,0820 00For
American Century22,2040 00For
State Street20,2970 00For
Equitable18,9280 00For
AllianceBernstein14,9890 00For
QUANTITATIVE MASTER SERIES LLC12,7910 00For
RMB INVESTORS TRUST12,3210 00For
Lincoln Financial11,4280 00For
MASTER INVESTMENT PORTFOLIO10,4480 00For
Voya10,2070 00For
Nationwide9,4520 00For

Showing the 25 largest of 77 asset managers. See all 77 in the interactive database.

2. Elect Director: James Hawkins

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

78% Majority: yes · of votes cast

FOR 78%WITHHELD
FOR: 8,244,802WITHHELD: 2,366,134
Details: description as filed, official tally, votes by 77 asset managers

Description as filed by funds: Election of Directors: James Hawkins

IRadimed Corporation’s own tally for this item (“Elect Director: James Hawkins”): 8,244,802 for, 2,366,134 withheld, per its Form 8-K filed June 24, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Stockholders elected each of Roger Susi, Monty Allen, Joe Kiani, Hilda Scharen-Guivel and James Hawkins to Iradimed's Board of Directors, each to hold office until a succeeding annual meeting of stockholders or until such director's successor shall have been duly elected and qualified (or, if earli…”
Support: 78% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 77 asset managers below reported 1,676,582 for, 714,316 withheld, 5,594 abstained.

FORWITHHOLD
FOR: 1,676,582ABSTAIN: 5,594WITHHOLD: 714,316
Largest asset managers voting on “Election of Directors: James Hawkins” at IRadimed Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard469,9640 9389For
BlackRock423,1790 00For
Fidelity75,8680 0260,173Mixed
T. Rowe Price167,5850 00For
Virtus147,2870 02,521For
Jackson National95,6830 2,8680For
TIAA00 084,792Withhold
First Trust00 076,355Withhold
Charles Schwab00 066,783Withhold
Dimensional00 051,678Withhold
Goldman Sachs51,1080 00For
Russell Investments00 045,905Withhold
Calamos43,4310 00For
WisdomTree36,3360 00For
Victory Capital00 026,082Withhold
American Century22,2040 00For
State Street20,2540 043For
Equitable18,9280 00For
AllianceBernstein14,9890 00For
QUANTITATIVE MASTER SERIES LLC12,7910 00For
RMB INVESTORS TRUST00 012,321Withhold
Lincoln Financial5,6000 05,828Mixed
MASTER INVESTMENT PORTFOLIO10,4480 00For
Voya10,2070 00For
Nationwide8,8780 0574Mixed

Showing the 25 largest of 77 asset managers. See all 77 in the interactive database.

3. Elect Director: Joe Kiani

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 10,492,206WITHHELD: 118,730
Details: description as filed, official tally, votes by 77 asset managers

Description as filed by funds: Election of Directors: Joe Kiani

IRadimed Corporation’s own tally for this item (“Elect Director: Joe Kiani”): 10,492,206 for, 118,730 withheld, per its Form 8-K filed June 24, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Stockholders elected each of Roger Susi, Monty Allen, Joe Kiani, Hilda Scharen-Guivel and James Hawkins to Iradimed's Board of Directors, each to hold office until a succeeding annual meeting of stockholders or until such director's successor shall have been duly elected and qualified (or, if earli…”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 77 asset managers below reported 2,391,582 for, 4,910 withheld.

FOR
FOR: 2,391,582WITHHOLD: 4,910
Largest asset managers voting on “Election of Directors: Joe Kiani” at IRadimed Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard470,3620 00For
BlackRock423,1790 00For
Fidelity336,0410 00For
T. Rowe Price166,5890 0996For
Virtus149,8080 00For
Jackson National98,5510 00For
TIAA84,7920 00For
First Trust76,3550 00For
Charles Schwab66,7830 00For
Dimensional51,6780 00For
Goldman Sachs51,1080 00For
Russell Investments45,9050 00For
Calamos43,4310 00For
WisdomTree36,3360 00For
Victory Capital26,0820 00For
American Century22,2040 00For
State Street20,2970 00For
Equitable18,9280 00For
AllianceBernstein14,9890 00For
QUANTITATIVE MASTER SERIES LLC12,7910 00For
RMB INVESTORS TRUST12,3210 00For
Lincoln Financial11,4280 00For
MASTER INVESTMENT PORTFOLIO10,4480 00For
Voya10,2070 00For
Nationwide9,4520 00For

Showing the 25 largest of 77 asset managers. See all 77 in the interactive database.

4. Elect Director: Monty Allen

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

87% Majority: yes · of votes cast

FOR 87%
FOR: 9,266,549WITHHELD: 1,344,387
Details: description as filed, official tally, votes by 77 asset managers

Description as filed by funds: Election of Directors: Monty Allen

IRadimed Corporation’s own tally for this item (“Elect Director: Monty Allen”): 9,266,549 for, 1,344,387 withheld, per its Form 8-K filed June 24, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Stockholders elected each of Roger Susi, Monty Allen, Joe Kiani, Hilda Scharen-Guivel and James Hawkins to Iradimed's Board of Directors, each to hold office until a succeeding annual meeting of stockholders or until such director's successor shall have been duly elected and qualified (or, if earli…”
Support: 87% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 77 asset managers below reported 1,771,512 for, 176,715 withheld, 448,265 abstained.

FORABSTAIN
FOR: 1,771,512ABSTAIN: 448,265WITHHOLD: 176,715
Largest asset managers voting on “Election of Directors: Monty Allen” at IRadimed Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard469,9690 4389For
BlackRock00 423,1790Abstain
Fidelity330,3970 05,644For
T. Rowe Price167,5850 00For
Virtus149,8080 00For
Jackson National98,5510 00For
TIAA00 084,792Withhold
First Trust76,3550 00For
Charles Schwab66,7830 00For
Dimensional51,6780 00For
Goldman Sachs51,1080 00For
Russell Investments00 045,905Withhold
Calamos43,4310 00For
WisdomTree36,3360 00For
Victory Capital26,0820 00For
American Century22,2040 00For
State Street20,2960 01For
Equitable5,9800 012,948Mixed
AllianceBernstein14,9890 00For
QUANTITATIVE MASTER SERIES LLC00 12,7910Abstain
RMB INVESTORS TRUST12,3210 00For
Lincoln Financial11,4280 00For
MASTER INVESTMENT PORTFOLIO00 10,4480Abstain
Voya10,2070 00For
Nationwide7,2140 02,238Mixed

Showing the 25 largest of 77 asset managers. See all 77 in the interactive database.

5. Elect Director: Roger Susi

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

81% Majority: yes · of votes cast

FOR 81%WITHHELD
FOR: 8,638,178WITHHELD: 1,972,758
Details: description as filed, official tally, votes by 76 asset managers

Description as filed by funds: Election of Directors: Roger Susi

IRadimed Corporation’s own tally for this item (“Elect Director: Roger Susi”): 8,638,178 for, 1,972,758 withheld, per its Form 8-K filed June 24, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Stockholders elected each of Roger Susi, Monty Allen, Joe Kiani, Hilda Scharen-Guivel and James Hawkins to Iradimed's Board of Directors, each to hold office until a succeeding annual meeting of stockholders or until such director's successor shall have been duly elected and qualified (or, if earli…”
Support: 81% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 76 asset managers below reported 1,887,228 for, 499,906 withheld, 5,427 abstained.

FORWITHHOLD
FOR: 1,887,228ABSTAIN: 5,427WITHHOLD: 499,906
Largest asset managers voting on “Election of Directors: Roger Susi” at IRadimed Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard470,3550 70For
BlackRock423,1790 00For
Fidelity75,8680 0260,173Mixed
T. Rowe Price167,5850 00For
Virtus147,2870 02,521For
Jackson National95,6830 2,8680For
TIAA84,7920 00For
First Trust00 076,355Withhold
Charles Schwab66,7830 00For
Dimensional00 051,678Withhold
Goldman Sachs51,1080 00For
Russell Investments45,9050 00For
Calamos43,4310 00For
WisdomTree36,3360 00For
Victory Capital00 026,082Withhold
American Century22,2040 00For
State Street20,2610 036For
Equitable18,9280 00For
AllianceBernstein14,9890 00For
QUANTITATIVE MASTER SERIES LLC12,7910 00For
RMB INVESTORS TRUST00 012,321Withhold
Lincoln Financial5,6000 05,828Mixed
MASTER INVESTMENT PORTFOLIO10,4480 00For
Voya00 010,207Withhold
Nationwide9,4520 00For

Showing the 25 largest of 76 asset managers. See all 76 in the interactive database.

6. 3. An advisory resolution on the compensation of Iradimed's named executive officers

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 11 wordings of this item as funds reported it.

99% Approved · of votes cast

FOR 99%
FOR: 10,487,387AGAINST: 106,030
Details: description as filed, official tally, votes by 279 asset managers

Description as filed by funds: To approve, on a non-binding advisory basis, a resolution on the fiscal 2025 compensation of the Company's named executive officers.

IRadimed Corporation’s own tally for this item (“3. An advisory resolution on the compensation of Iradimed's named executive officers”): 10,487,387 for, 106,030 against — passed, per its Form 8-K filed June 24, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Stockholders approved an advisory resolution on the compensation of Iradimed's named executive officers.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 78 asset managers voting on “To approve, on a non-binding advisory basis, a resolution on the fiscal 2025 compensation of the Company's nam” at IRadimed Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard470,3620 00For
BlackRock423,1790 00For
Fidelity336,0410 00For
T. Rowe Price167,5850 00For
Virtus149,8080 00For
Jackson National98,5510 00For
TIAA84,7920 00For
First Trust76,3550 00For
Charles Schwab66,7830 00For
Dimensional51,6780 00For
Goldman Sachs51,1080 00For
Russell Investments45,9050 00For
Calamos43,4310 00For
WisdomTree36,3360 00For
Victory Capital26,0820 00For
American Century22,2040 00For
State Street20,2970 00For
Equitable18,9280 00For
AllianceBernstein14,9890 00For
QUANTITATIVE MASTER SERIES LLC12,7910 00For
RMB INVESTORS TRUST12,3210 00For
Lincoln Financial11,4280 00For
MASTER INVESTMENT PORTFOLIO10,4480 00For
Voya10,2070 00For
Nationwide9,4520 00For

Fund voting reports, all 78 managers: 2,400,700 for, 5,800 withheld, 3,914 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 223 asset managers voting on “To approve, on a non-binding advisory basis, a resolution on the fiscal 2025 compensation of the Company's nam” at IRadimed Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock406,6080 00For
Renaissance340,5800 00For
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC336,3390 00For
GEODE CAPITAL MANAGEMENT, LLC290,0750 00For
Nine Ten Capital Management LLC279,0620 00For
T. Rowe Price270,5940 00For
Copeland Capital Management, LLC204,6870 00For
State Street192,8560 00For
ACADIAN ASSET MANAGEMENT LLC123,497277 00For
Northern Trust113,2200 00For
Goldman Sachs97,6080 00For
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM95,4230 00For
Nuveen88,5810 00For
Russell Investments80,4660 00For
Fidelity71,2100 00For
Vanguard68,7500 00For
Two Sigma67,8980 00For
Charles Schwab66,9360 00For
Ranger Investment Management, L.P.57,8450 00For
ENVESTNET ASSET MANAGEMENT INC49,9460 00For
Lazard047,635 00Against
AMERIPRISE FINANCIAL INC43,8960 00For
ALGERT GLOBAL LLC00 42,9750Abstain
TUDOR INVESTMENT CORP ET AL42,3280 00For
SEI39,4690 00For

Institutional-manager reports, all 223 managers: 4,293,928 for, 97,286 against, 43,273 abstained, 108 not voted. Showing the 25 largest; see all in the interactive database.

7. 2. The selection of RSM US LLP as Iradimed's independent registered public accounting firm to perform independent audit…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%
FOR: 11,355,891AGAINST: 8,716
Details: description as filed, official tally, votes by 76 asset managers

Description as filed by funds: To ratify the appointment of RSM US LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026; and

IRadimed Corporation’s own tally for this item (“2. The selection of RSM US LLP as Iradimed's independent registered public accounting firm to perform independent audit services for the fiscal year ending December 31, 2026, as set forth below”): 11,355,891 for, 8,716 against — passed, per its Form 8-K filed June 24, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Stockholders ratified the selection of RSM US LLP as Iradimed's independent registered public accounting firm to perform independent audit services for the fiscal year ending December 31, 2026, as set forth below.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of IRadimed Corporation’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify Appointment of Independent Auditors” (2 managers, 8,050 for).

The 76 asset managers below reported 2,390,326 for, 1 against, 3,914 abstained.

FOR
FOR: 2,390,326AGAINST: 1ABSTAIN: 3,914
Largest asset managers voting on “To ratify the appointment of RSM US LLP as the independent registered public accounting firm of the Company fo” at IRadimed Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard470,3620 00For
BlackRock423,1790 00For
Fidelity336,0410 00For
T. Rowe Price167,5850 00For
Virtus149,8080 00For
Jackson National98,5510 00For
TIAA84,7920 00For
First Trust76,3550 00For
Charles Schwab66,7830 00For
Dimensional51,6780 00For
Goldman Sachs51,1080 00For
Russell Investments45,9050 00For
Calamos43,4310 00For
WisdomTree36,3360 00For
Victory Capital26,0820 00For
American Century22,2040 00For
State Street20,2961 00For
Equitable18,9280 00For
AllianceBernstein14,9890 00For
QUANTITATIVE MASTER SERIES LLC12,7910 00For
RMB INVESTORS TRUST12,3210 00For
Lincoln Financial11,4280 00For
MASTER INVESTMENT PORTFOLIO10,4480 00For
Voya10,2070 00For
Nationwide9,4520 00For

Showing the 25 largest of 76 asset managers. See all 76 in the interactive database.

Largest IRadimed Corporation shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 12,783,035 shares outstanding at the time of that meeting.

Fund voting reports: top IRadimed Corporation shareholders by shares voted on “To approve, on a non-binding advisory basis, a resolution on the fiscal 2025 compensation of…”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 3.68%
2BlackRock 3.31%
3Fidelity 2.63%
4T. Rowe Price 1.31%
5Virtus 1.17%
6Jackson National 0.77%
7TIAA 0.66%
8First Trust 0.60%
9Charles Schwab 0.52%
10Dimensional 0.40%
Institutional-manager reports: top IRadimed Corporation shareholders by shares voted on “To approve, on a non-binding advisory basis, a resolution on the fiscal 2025 compensation of…”, 2025-2026
#Asset manager % of shares outstanding
1BlackRock 3.18%
2Renaissance 2.66%
3KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 2.63%
4GEODE CAPITAL MANAGEMENT, LLC 2.27%
5Nine Ten Capital Management LLC 2.18%
6T. Rowe Price 2.12%
7Copeland Capital Management, LLC 1.60%
8State Street 1.51%
9ACADIAN ASSET MANAGEMENT LLC 0.97%
10Northern Trust 0.89%

Reported IRadimed Corporation holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

IRadimed Corporation holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
Roger E. Susi 34.82% 13G
Roger Susi 34.64% DEF14A
BlackRock 7.57% 13F
Vanguard Group 4.38% 13F
Renaissance Technologies 3.45% 13F
Geode Capital 2.24% 13F
Dimensional Fund Advisors 1.77% 13F
State Street 1.60% 13F
Goldman Sachs 1.55% 13F
Two Sigma 1.30% 13F

Percentages above are of 12,783,035 shares outstanding, as reported by IRadimed Corporation on its Form 10-Q dated April 30, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from IRadimed Corporation’s 10-Q dated April 30, 2026. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.

At IRadimed Corporation's shareholder meeting held June 23, 2026, in the 2025-2026 proxy season, 280 asset managers reported how they voted on 7 ballot items in their SEC Form N-PX filings, covering 1,875 separate fund positions. On the most widely held item on that ballot — To approve, on a non-binding advisory basis, a resolution on the fiscal 2025 compensation of… — IRadimed Corporation's filing reports the proposal as approved, with 99% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: IRadimed Corporation's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 24, 2026.

IRadimed Corporation proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.